{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T23:10:18Z","timestamp":1739056218790,"version":"3.37.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,8]]},"DOI":"10.7759\/cureus.78744","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T22:36:26Z","timestamp":1739054186000},"source":"Crossref","is-referenced-by-count":0,"title":["Modeling Liver Fibrosis Progression in Patients With Viral Hepatitis Using the Machine Learning Tool Subtype and Stage Inference (SuStaIn)"],"prefix":"10.7759","author":[{"given":"Akiyoshi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wijeratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Saiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Kuwatsuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo AA","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001, 344:495-500. 10.1056\/NEJM200102153440706","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak K","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al.. Histological grading and staging of chronic hepatitis. J Hepatol. 1995, 22:696-9. 10.1016\/0168-8278(95)80226-6","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet VJ","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994, 19:1513-20.","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper EB","year":"2017","unstructured":"Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017, 377:756-68. 10.1056\/NEJMra1610570","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev A","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ, et al.. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002, 97:2614-8. 10.1111\/j.1572-0241.2002.06038.x","journal-title":"Am J Gastroenterol"},{"key":"ref6","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group","volume":"20","year":"1994","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994, 20.15-20.","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.241","article-title":"Cost-effective evaluation of nonalcoholic fatty liver disease with NAFLD fibrosis score and vibration controlled transient elastography","volume":"110","author":"Tapper EB","year":"2015","unstructured":"Tapper EB, Sengupta N, Hunink MG, Afdhal NH, Lai M. Cost-effective evaluation of nonalcoholic fatty liver disease with NAFLD fibrosis score and vibration controlled transient elastography. Am J Gastroenterol. 2015, 110:1298-304. 10.1038\/ajg.2015.241","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.21956","article-title":"Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?","volume":"30","author":"Motosugi U","year":"2009","unstructured":"Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, Araki T. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?. J Magn Reson Imaging. 2009, 30:1042-6. 10.1002\/jmri.21956","journal-title":"J Magn Reson Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.23758","article-title":"Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio","volume":"36","author":"Goshima S","year":"2012","unstructured":"Goshima S, Kanematsu M, Watanabe H, Kondo H, Kawada H, Moriyama N, Bae KT. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging. 2012, 36:1148-53. 10.1002\/jmri.23758","journal-title":"J Magn Reson Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100621","article-title":"Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations","volume":"259","author":"Watanabe H","year":"2011","unstructured":"Watanabe H, Kanematsu M, Goshima S, Kondo H, Onozuka M, Moriyama N, Bae KT. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology. 2011, 259:142-50. 10.1148\/radiol.10100621","journal-title":"Radiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling RK","year":"2025","unstructured":"Sterling RK, Patel K, Duarte-Rojo A, et al.. AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025, 81:321-57. 10.1097\/HEP.0000000000000845","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-26. 10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.01.062","article-title":"An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease","volume":"60","author":"Fonteijn HM","year":"2012","unstructured":"Fonteijn HM, Modat M, Clarkson MJ, et al.. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. NeuroImage. 2012, 60:1880-9. 10.1016\/j.neuroimage.2012.01.062","journal-title":"NeuroImage"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-023-00779-6","article-title":"Data-driven modelling of neurodegenerative disease progression: thinking outside the black box","volume":"25","author":"Young AL","year":"2024","unstructured":"Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, Alexander DC. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nat Rev Neurosci. 2024, 25:111-30. 10.1038\/s41583-023-00779-6","journal-title":"Nat Rev Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2021.613261","article-title":"Ordinal SuStaIn: Subtype and stage inference for clinical scores, visual ratings, and other ordinal data","volume":"4","author":"Young AL","year":"2021","unstructured":"Young AL, Vogel JW, Aksman LM, et al.. Ordinal SuStaIn: Subtype and stage inference for clinical scores, visual ratings, and other ordinal data. Front Artif Intell. 2021, 4:613261. 10.3389\/frai.2021.613261","journal-title":"Front Artif Intell"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1600OC","article-title":"Disease progression modeling in chronic obstructive pulmonary disease","volume":"201","author":"Young AL","year":"2020","unstructured":"Young AL, Bragman FJ, Rangelov B, et al.. Disease progression modeling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020, 201:294-302. 10.1164\/rccm.201908-1600OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference","volume":"9","author":"Young AL","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, et al.. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018, 9:4273. 10.1038\/s41467-018-05892-0","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.814768","article-title":"Temporal progression patterns of brain atrophy in corticobasal syndrome and progressive supranuclear palsy revealed by subtype and stage inference (SuStaIn)","volume":"13","author":"Saito Y","year":"2022","unstructured":"Saito Y, Kamagata K, Wijeratne PA, et al.. Temporal progression patterns of brain atrophy in corticobasal syndrome and progressive supranuclear palsy revealed by subtype and stage inference (SuStaIn). Front Neurol. 2022, 13:814768. 10.3389\/fneur.2022.814768","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24725","article-title":"Upper limits of normal for alanine aminotransferase activity in the United States population","volume":"55","author":"Ruhl CE","year":"2012","unstructured":"Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology. 2012, 55:447-54. 10.1002\/hep.24725","journal-title":"Hepatology"},{"key":"ref20","article-title":"Markov Chain Monte Carlo Maximum Likelihood","author":"Geyer CJ","year":"1991","unstructured":"Geyer CJ. Markov Chain Monte Carlo Maximum Likelihood. Interface Foundation of North America, United States; 1991."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa461","article-title":"Sequence of clinical and neurodegeneration events in Parkinson's disease progression","volume":"144","author":"Oxtoby NP","year":"2021","unstructured":"Oxtoby NP, Leyland LA, Aksman LM, et al.. Sequence of clinical and neurodegeneration events in Parkinson's disease progression. Brain. 2021, 144:975-88. 10.1093\/brain\/awaa461","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02780-w","article-title":"AST\/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran","volume":"23","author":"Moosavy SH","year":"2023","unstructured":"Moosavy SH, Eftekhar E, Davoodian P, Nejatizadeh A, Shadman M, Zare S, Nazarnezhad MA. AST\/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterol. 2023, 23:145. 10.1186\/s12876-023-02780-w","journal-title":"BMC Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2021.104543","article-title":"FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study","volume":"7","author":"Catanzaro R","year":"2021","unstructured":"Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol. 2021, 7:111-6. 10.5114\/ceh.2021.104543","journal-title":"Clin Exp Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4459-4","article-title":"The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China","volume":"19","author":"Huang D","year":"2019","unstructured":"Huang D, Lin T, Wang S, et al.. The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China. BMC Infect Dis. 2019, 19:878. 10.1186\/s12879-019-4459-4","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-020-00978-6","article-title":"Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics","volume":"38","author":"Ozaki K","year":"2020","unstructured":"Ozaki K, Kozaka K, Kosaka Y, Kimura H, Gabata T. Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics. Jpn J Radiol. 2020, 38:833-52. 10.1007\/s11604-020-00978-6","journal-title":"Jpn J Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100468","article-title":"Selective atrophy of the middle hepatic venous drainage area in hepatitis C-related cirrhotic liver: morphometric study by using multidetector CT","volume":"257","author":"Ozaki K","year":"2010","unstructured":"Ozaki K, Matsui O, Kobayashi S, et al.. Selective atrophy of the middle hepatic venous drainage area in hepatitis C-related cirrhotic liver: morphometric study by using multidetector CT. Radiology. 2010, 257:705-14. 10.1148\/radiol.10100468","journal-title":"Radiology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2181","article-title":"Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT","volume":"189","author":"Zhou XP","year":"2007","unstructured":"Zhou XP, Lu T, Wei YG, Chen XZ. Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT. Am J Roentgenol. 2007, 189:W153-9. 10.2214\/AJR.07.2181","journal-title":"Am J Roentgenol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.629","article-title":"Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma","volume":"3","author":"Kubota K","year":"2012","unstructured":"Kubota K, Tamura T, Aoyama N, Nogami M, Hamada N, Nishioka A, Ogawa Y. Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma. Oncol Lett. 2012, 3:990-4. 10.3892\/ol.2012.629","journal-title":"Oncol Lett"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02041-z","article-title":"Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers","volume":"44","author":"Jang HJ","year":"2019","unstructured":"Jang HJ, Min JH, Lee JE, Shin KS, Kim KH, Choi SY. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers. Abdom Radiol. 2019, 44:2769-80. 10.1007\/s00261-019-02041-z","journal-title":"Abdom Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331953-modeling-liver-fibrosis-progression-in-patients-with-viral-hepatitis-using-the-machine-learning-tool-subtype-and-stage-inference-sustain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T22:36:27Z","timestamp":1739054187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331953-modeling-liver-fibrosis-progression-in-patients-with-viral-hepatitis-using-the-machine-learning-tool-subtype-and-stage-inference-sustain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.78744","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,8]]}}}